Clinical & Translational Oncology

Papers
(The median citation count of Clinical & Translational Oncology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Benefits of early salvage therapy on oncological outcomes in high-risk prostate cancer with persistent PSA after radical prostatectomy55
MiR-493-5p inhibits the malignant development of gliomas via suppressing E2F3-mediated dysfunctions of P53 and PI3K/AKT pathways52
SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis51
Clinical nutrition as part of the treatment pathway of pancreatic cancer patients: an expert consensus36
Quality indicators and excellence requirements for a multidisciplinary lung cancer tumor board by the Spanish Lung Cancer Group34
The TRIM proteins in cancer: from expression to emerging regulatory mechanisms31
Circulating exosomal miRNAs and cancer early diagnosis25
Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism25
PD1/PDL1 expression is associated with increased TIM3 expression and tumor-infiltrating T lymphocytes in fibroblastic tumors24
Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-324
The effects of aerobic exercise on the intestinal tumors and flora of the ApcMin/+ mouse20
Multidisciplinary consensus on the criteria for fertility preservation in cancer patients20
Correction to: The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database18
Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for tre17
Long-term outcomes of spinal SBRT. Is it important to select the treatment time?14
Stereotactic body radiotherapy for early-stage non-small cell lung cancer: a multicentre study by the Oncologic Group for the Study of Lung Cancer (Spanish Radiation Oncology Society)13
In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types12
Expressions of PD-L1 and Nectin-4 in urothelial cancer patients treated with pembrolizumab12
Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects12
Measures to evaluate quality of care in renal cancer: results of a Delphi study in Spain10
Linezolid-induced thrombocytopenia in patients with acute myeloid leukemia: a matched case–control study9
Identification of a novel cancer microbiome signature for predicting prognosis of human breast cancer patients9
Post-hematopoietic stem cell transplant squamous cell carcinoma in patients with Fanconi anemia: a dreadful enemy9
Clinical and molecular characteristics of epidermal growth factor receptor exon 20 insertion mutations in non-small-cell lung cancer9
0.032886028289795